Marizyme Inc (MRZM)
0.09
+0.01
(+12.50%)
USD |
OTCM |
May 17, 16:00
Marizyme Total Liabilities (Quarterly): 26.68M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 26.68M |
September 30, 2023 | 58.87M |
June 30, 2023 | 29.71M |
March 31, 2023 | 23.04M |
December 31, 2022 | 21.27M |
September 30, 2022 | 22.78M |
June 30, 2022 | 22.95M |
March 31, 2022 | 19.76M |
December 31, 2021 | 18.31M |
September 30, 2021 | 13.26M |
June 30, 2021 | 2.797M |
March 31, 2021 | 1.727M |
December 31, 2020 | 1.796M |
September 30, 2020 | 0.4661M |
June 30, 2020 | 0.4416M |
March 31, 2020 | 0.3955M |
December 31, 2019 | 0.2702M |
September 30, 2019 | 0.0726M |
June 30, 2019 | 0.2127M |
March 31, 2019 | 0.0954M |
December 31, 2018 | 0.0428M |
September 30, 2018 | 0.0802M |
December 31, 2017 | 0.6527M |
December 31, 2013 | 1.295M |
September 30, 2013 | 16.87M |
Date | Value |
---|---|
June 30, 2013 | 17.66M |
March 31, 2013 | 16.59M |
December 31, 2012 | 5.301M |
September 30, 2012 | 22.43M |
June 30, 2012 | 25.20M |
March 31, 2012 | 26.87M |
December 31, 2011 | 25.64M |
September 30, 2011 | 26.16M |
June 30, 2011 | 25.32M |
March 31, 2011 | 24.29M |
December 31, 2010 | 0.5482M |
September 30, 2010 | 0.0367M |
June 30, 2010 | 0.0205M |
March 31, 2010 | 23.82M |
December 31, 2009 | 0.04M |
September 30, 2009 | 0.3023M |
June 30, 2009 | 0.0238M |
March 31, 2009 | 0.0171M |
December 31, 2008 | 0.0296M |
September 30, 2008 | 0.0363M |
June 30, 2008 | 0.0392M |
March 31, 2008 | 0.0311M |
December 31, 2007 | 0.0167M |
September 30, 2007 | 0.0118M |
June 30, 2007 | 0.0065M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
0.0726M
Minimum
Sep 2019
58.87M
Maximum
Sep 2023
13.94M
Average
13.26M
Median
Sep 2021
Total Liabilities (Quarterly) Benchmarks
NovaBay Pharmaceuticals Inc | 5.197M |
Palatin Technologies Inc | 9.827M |
iBio Inc | 24.82M |
Theriva Biologics Inc | 14.61M |
Oragenics Inc | 1.798M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 22.02M |
Shareholders Equity (Quarterly) | -4.661M |
Debt to Equity Ratio | -3.780 |
Current Ratio | 0.047 |
Net Debt Paydown Yield | -23.88% |